Cover Image
市場調查報告書

全球細胞增生市場趨勢,機會分析,市場佔有率,預測

Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 374049
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球細胞增生市場趨勢,機會分析,市場佔有率,預測 Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日期: 2016年09月26日 內容資訊: 英文 140 Pages
簡介

本報告提供全球細胞增生市場相關調查,市場概要與趨勢,各分類市場,各地區趨勢,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 市場趨勢
  • 競爭環境
  • 波特五力分析模式
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各類型
  • 各終端用戶
  • 各用途
  • 各產品

第5章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 企業簡介

目錄
Product Code: HBI-3421016

The global Cell Expansion market is estimated to grow at CAGR of 18.1% during 2016-2022. The Cell Expansion is segmented on the basis of application, cell type, product, end user and geography. The application segment is segmented into Cancer and Cell-Based Research, Regenerative Medicine and Stem Cell Research and Others. The end user segment is also segmented into Biopharmaceutical and Biotechnology Companies, Cell Banks, Research Institutes and Others. The cell type segment is segmented into Animal Cells and Human Cells.

The Cell Expansion market is dominated by some of the major key players such as Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic's PLC, Celgene Corporation, GE Healthcare, Lonza Group Ltd., Merck KGAA, Stemcell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc. In 2015, the Medtronic has announced that they had completed the acquisition of Covidien plc. Was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices.

The Increased funding by government and private firms in research and development are snowballing the scope of Cell Expansion market. Although the growing and increasing healthcare spending across the globe is also driving the growth in the global Cell Expansion market. The rising prevalence of chronic diseases in the world are creating huge scope for Cell Expansion market. However, the increasing technology advancement is one of the key factor which is generating huge scope in Cell Expansion market. In last decade there are a lot of mergers, acquisition and other strategic initiative taken by various key players to develop the new technology in the Cell Expansion market.

The Cell Expansion market is majorly driven by prevalence of chronic lifestyle diseases is increasing the scope of Cell Expansion in the global market. However, the Ethical Issues for Research and Development to Use of Embryonic Stem Cell and Stringent Government policies may hinder the growth in the global Cell Expansion market. The global Cell Expansion market is having huge opportunities such as Huge growth opportunity in the emerging countries, New 3d cell expansion technology and increasing spending on the research and development of Cell Expansion is expected to contribute a lot in the growth of global Cell Expansion market and Untapped Asia Pacific region has huge scope for Cell Expansion market.

North America dominates the Cell Expansion market, the domination is due to presence of some key player of Cell Expansion who are dominating and contributing the large share in the global market. The growth of North America is driven by number of factors such as technological advancement, expansion in product innovation and increasing in number of patients of diabetes and orthopedic. APAC is the fastest growing region in the world. The APAC is growing with an impressive CAGR in the forecasted period. The growth is driven by growing demand for stem cell therapy is excepted to boost the Asia Pacific Cell Expansion market. The growing demand for low cost treatment in the world is also injecting huge growth opportunity in the Asia Pacific region.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP REVENUE GENERATING SEGMENTS
    • 2.4.2. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.3. TOP GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. GROWING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. INCREASING GOVERNMENT INVESTMENTS ON CELL BASED RESEARCH
    • 3.1.3. HUGE SPENDING BY THE COMPANIES TO DEVELOP CELL BASED THERAPIES ON RESEARCH AND DEVELOPMENT
    • 3.1.4. GROWING NUMBER OF GMP-CERTIFIED CELL THERAPY PRODUCTION FACILITIES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. STRINGENT REGULATORY APPROVAL PROCESS
    • 3.2.2. HIGH COST OF RESEARCH AND DEVELOPMENT
    • 3.2.3. ETHICAL ANXIETIES REGARDING RESEARCH ON CELL BIOLOGY
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. HUGE GROWTH OPPORTUNITY IN THE EMERGING COUNTRIES
    • 3.3.2. NEW 3D CELL EXPANSION TECHNOLOGY
    • 3.3.3. GROWING AGING POPULATION
  • 3.4. MARKET CHALLENGES
    • 3.4.1. SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS
    • 3.4.2. HIGH COSTS OF STEM CELL PROCESSING
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. BY TYPE
    • 4.1.1. GLOBAL ANIMAL CELLS MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL HUMAN CELLS MARKET 2014-2022 ($ MILLION)
      • 4.1.2.1. GLOBAL STEM CELLS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.1.1. GLOBAL ADULT STEM CELLS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.1.2. GLOBAL EMBRYONIC STEM CELLS MARKET 2014-2022 ($ MILLION)
        • 4.1.2.1.3. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET 2014-2022 ($ MILLION)
      • 4.1.2.2. GLOBAL DIFFERENTIATED CELLS MARKET 2014-2022 ($ MILLION)
  • 4.2. BY END USER
    • 4.2.1. GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL CELL BANKS MARKET 2014-2022 ($ MILLION)
    • 4.2.3. GLOBAL RESEARCH INSTITUTES MARKET 2014-2022 ($ MILLION)
    • 4.2.4. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 4.3. BY APPLICATION
    • 4.3.1. GLOBAL CANCER AND CELL-BASED RESEARCH MARKET 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL CELL EXPANSION AND STEM CELL RESEARCH MARKET 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 4.4. BY PRODUCT
    • 4.4.1. GLOBAL CONSUMABLES MARKET 2014-2022 ($ MILLION)
      • 4.4.1.1. GLOBAL DISPOSABLES MARKET 2014-2022 ($ MILLION)
        • 4.4.1.1.1. GLOBAL BIOREACTOR ACCESSORIES MARKET 2014-2022 ($ MILLION)
        • 4.4.1.1.2. GLOBAL TISSUE CULTURE FLASKS MARKET 2014-2022 ($ MILLION)
        • 4.4.1.1.3. GLOBAL OTHER DISPOSABLES MARKET 2014-2022 ($ MILLION)
      • 4.4.1.2. GLOBAL REAGENTS, MEDIA, AND SERUM MARKET 2014-2022 ($ MILLION)
    • 4.4.2. GLOBAL INSTRUMENTS MARKET 2014-2022 ($ MILLION)
      • 4.4.2.1. GLOBAL AUTOMATED CELL EXPANSION SYSTEMS MARKET 2014-2022 ($ MILLION)
      • 4.4.2.2. GLOBAL BIOREACTORS MARKET 2014-2022 ($ MILLION)
        • 4.4.2.2.1. GLOBAL MICROCARRIER BIOREACTORS MARKET 2014-2022 ($ MILLION)
          • 4.4.2.2.1.1. GLOBAL MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET 2014-2022 ($ MILLION)
          • 4.4.2.2.1.2. GLOBAL SUSPENSION-BASED ANCHORAGE INDEPENDENT BIOREACTORS MARKET 2014-2022 ($ MILLION)
        • 4.4.2.2.2. GLOBAL PERFUSION/HOLLOW FIBER BIOREACTORS MARKET 2014-2022 ($ MILLION)
      • 4.4.2.3. GLOBAL CELL EXPANSION SUPPORTING EQUIPMENT MARKET 2014-2022 ($ MILLION)
        • 4.4.2.3.1. GLOBAL CELL COUNTERS MARKET 2014-2022 ($ MILLION)
        • 4.4.2.3.2. GLOBAL CENTRIFUGES MARKET 2014-2022 ($ MILLION)
        • 4.4.2.3.3. GLOBAL FLOW CYTOMETERS MARKET 2014-2022 ($ MILLION)
        • 4.4.2.3.4. GLOBAL OTHER SUPPORTING EQUIPMENT MARKET 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.3.4. AUSTRALIA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.3.5. ROAPAC CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES

  • 1. BECKMAN COULTER, INC.
  • 2. BECTON, DICKINSON AND COMPANY
  • 3. BIOHEART
  • 4. CORNING, INC.
  • 5. MEDTRONIC'S PLC
  • 6. CELGENE CORPORATION
  • 7. GE HEALTHCARE
  • 8. LONZA GROUP LTD.
  • 9. MERCK KGAA
  • 10. MILTENYI BIOTEC
  • 11. OPEXA THERAPEUTICS
  • 12. STEMCELL TECHNOLOGIES
  • 13. STRYKER CORPORATION
  • 14. TERUMO BCT, INC.
  • 15. THERMO FISHER SCIENTIFIC, INC.

LIST OF TABLES

  • 1. GLOBAL CELL EXPANSION MARKET BY APPLICATION 2014-2022 ($MILLION)
  • 2. GLOBAL CELL EXPANSION MARKET BY CELL TYPE 2014-2022 ($MILLION)
  • 3. GLOBAL CELL EXPANSION MARKET BY PRODUCT 2014-2022 ($MILLION)
  • 4. GLOBAL CELL EXPANSION MARKET BY END USER 2014-2022 ($MILLION)
  • 5. GLOBAL SYNTHETIC BONE SUBSTITUTE MARKET 2014-2022 ($ MILLION)
  • 6. NORTH AMERICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 7. EUROPE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 8. ASIA PACIFIC CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 9. REST OF THE WORLD CELL EXPANSION MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANIMAL CELLS MARKET 2014-2022 ($ MILLION)
  • 2. GLOBAL HUMAN CELLS MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL STEM CELLS MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL ADULT STEM CELLS MARKET 2014-2022 ($ MILLION)
  • 5. GLOBAL EMBRYONIC STEM CELLS MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL DIFFERENTIATED CELLS MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2014-2022 ($ MILLION)
  • 9. GLOBAL CELL BANKS MARKET 2014-2022 ($ MILLION)
  • 10. GLOBAL RESEARCH INSTITUTES MARKET 2014-2022 ($ MILLION)
  • 11. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 12. GLOBAL CANCER AND CELL-BASED RESEARCH MARKET 2014-2022 ($ MILLION)
  • 13. GLOBAL CELL EXPANSION AND STEM CELL RESEARCH MARKET 2014-2022 ($ MILLION)
  • 14. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 15. GLOBAL CONSUMABLES MARKET 2014-2022 ($ MILLION)
  • 16. GLOBAL DISPOSABLES MARKET 2014-2022 ($ MILLION)
  • 17. GLOBAL BIOREACTOR ACCESSORIES MARKET 2014-2022 ($ MILLION)
  • 18. GLOBAL TISSUE CULTURE FLASKS MARKET 2014-2022 ($ MILLION)
  • 19. GLOBAL OTHER DISPOSABLES MARKET 2014-2022 ($ MILLION)
  • 20. GLOBAL REAGENTS, MEDIA, AND SERUM MARKET 2014-2022 ($ MILLION)
  • 21. GLOBAL INSTRUMENTS MARKET 2014-2022 ($ MILLION)
  • 22. GLOBAL AUTOMATED CELL EXPANSION SYSTEMS MARKET 2014-2022 ($ MILLION)
  • 23. GLOBAL BIOREACTORS MARKET 2014-2022 ($ MILLION)
  • 24. GLOBAL MICROCARRIER BIOREACTORS MARKET 2014-2022 ($ MILLION)
  • 25. GLOBAL MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET 2014-2022 ($ MILLION)
  • 26. GLOBAL SUSPENSION-BASED ANCHORAGE INDEPENDENT BIOREACTORS MARKET 2014-2022 ($ MILLION)
  • 27. GLOBAL PERFUSION/HOLLOW FIBER BIOREACTORS MARKET 2014-2022 ($ MILLION)
  • 28. GLOBAL CELL EXPANSION SUPPORTING EQUIPMENT MARKET 2014-2022 ($ MILLION)
  • 29. GLOBAL CELL COUNTERS MARKET 2014-2022 ($ MILLION)
  • 30. GLOBAL CENTRIFUGES MARKET 2014-2022 ($ MILLION)
  • 31. GLOBAL FLOW CYTOMETERS MARKET 2014-2022 ($ MILLION)
  • 32. GLOBAL OTHER SUPPORTING EQUIPMENT MARKET 2014-2022 ($ MILLION)
  • 33. UNITED STATES (U.S.) CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 34. CANADA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 35. UNITED KINGDOM (UK) CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 36. FRANCE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 37. GERMANY CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 38. SPAIN CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 39. ITALY CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 40. ROE CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 41. INDIA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 42. CHINA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 43. JAPAN CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 44. AUSTRALIA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 45. ROAPAC CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 46. LATIN AMERICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 47. MENA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
  • 48. AFRICA CELL EXPANSION MARKET 2014-2022 ($ MILLION)
Back to Top